Lynparza 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV6R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,986
Award facts
- Contract value 100% obligated
- $48,986.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $48,986.44 by the Defense Logistics Agency on January 29, 2026, for the supply of Lynparza 100 mg tablets (120-count units). This firm fixed-price, non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 20, 2026. The award represents a task order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen serves as a critical vendor within the federal pharmaceutical supply chain, leveraging its parent company Cencora's extensive healthcare distribution infrastructure to fulfill government medical procurement requirements. The company's federal contract portfolio demonstrates sustained capability in delivering specialized pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order for Lynparza, an oncology medication, reflects the company's established role as a primary pharmaceutical distributor for military and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FQV6R?
SPE2DR26FQV6R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQV6R worth?
The government has obligated $48,986 on SPE2DR26FQV6R.
Is contract SPE2DR26FQV6R an order under another contract?
Yes. SPE2DR26FQV6R is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV6R competed?
The extent of competition for SPE2DR26FQV6R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award